Laura Rebolledo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Laura Rebolledo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Lué
Servicio de Aparato Digestivo Hospital Clínico Universitario Lozano Blesa Zaragoza Spain
1 shared publication Blanca Pilar Galindo-Torres
1 shared publication- Carmen Rodríguez-Vigil
Child and Adolescent Oncohematology Unit and Department of Pediatrics, Miguel Servet University Hospital, Saragossa, Spain
1 shared publication Emilio Vives-Ricomà
1 shared publication- Erika Alfambra
Aragon Health Research Institute (IIS Aragon), 50009 Zaragoza, Spain
1 shared publication - Eugenio Vicente
Department of Otorhinolaryngology and Head and Neck Surgery, Medical School of University of Zaragoza, Zaragoza, Spain
1 shared publication
Latest Publications
- Open Access
- 30 May 2023
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (10) , 4519-4530
Bacterial immunotherapy is highly effective in reducing recurrent upper respiratory tract infections in children: a prospective observational study
Purpose: Whilst immunotherapy is an appealing option as it could reduce the burden of recurrent pediatric respiratory tract infections (RTI), there is limited evidence on its effectiveness and more research was requested in order to better understand this therapeutic modality. Methods: We performed a prospective cohort study involving 57 subjects to assess the safety and effectiveness a 3-month regimen of either typified or patient-specific bacterial lysates could have in reducing the number of RTIs in children aged 0 to 11 years with histories of recurrent episodes. Results: After a 6-month follow-up, the number of RTIs and school absenteeism dropped sharply and significantly, from an adjusted mean (standard error) of 0.6 (0.04) episodes/month to 0.1 (0.03) episodes/month (74.7% reduction, P < 0.001), and from an adjusted mean score of 4.6 (1.06) points to 0.0 (0.01) points over 10 (99.5% reduction, P < 0.001), respectively. There was also a significant decrease in the severity of symptoms. No adverse reactions were observed. Conclusion: The use of the study product is associated with a decreased risk of recurrent RTIs in children, with a very favorable safety profile that warrants further investigation in randomized clinical trials.
- 30 May 2023
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (10) , 4519-4530
Open AccessBacterial immunotherapy is highly effective in reducing recurrent upper respiratory tract infections in children: a prospective observational study
Purpose: Whilst immunotherapy is an appealing option as it could reduce the burden of recurrent pediatric respiratory tract infections (RTI), there is limited evidence on its effectiveness and more research was requested in order to better understand this therapeutic modality. Methods: We performed a prospective cohort study involving 57 subjects to assess the safety and effectiveness a 3-month regimen of either typified or patient-specific bacterial lysates could have in reducing the number of RTIs in children aged 0 to 11 years with histories of recurrent episodes. Results: After a 6-month follow-up, the number of RTIs and school absenteeism dropped sharply and significantly, from an adjusted mean (standard error) of 0.6 (0.04) episodes/month to 0.1 (0.03) episodes/month (74.7% reduction, P < 0.001), and from an adjusted mean score of 4.6 (1.06) points to 0.0 (0.01) points over 10 (99.5% reduction, P < 0.001), respectively. There was also a significant decrease in the severity of symptoms. No adverse reactions were observed. Conclusion: The use of the study product is associated with a decreased risk of recurrent RTIs in children, with a very favorable safety profile that warrants further investigation in randomized clinical trials.
- 24 May 2017
- Published by Ediciones Universidad de Salamanca in Revista ORL
- Vol. 8 (4) , 205
Enfermedad ganglionar residual tras quimiorradioterapia con intención radical en pacientes con tumores de faringolaringe
- 24 May 2017
- Published by Ediciones Universidad de Salamanca in Revista ORL
- Vol. 8 (4) , 205
Enfermedad ganglionar residual tras quimiorradioterapia con intención radical en pacientes con tumores de faringolaringe